Biohaven (BHVN) Free Cash Flow (2021 - 2026)

Biohaven has disclosed Free Cash Flow across 6 years of filings, most recently posting -$149.9 million for Q1 2026.

• Free Cash Flow for Q1 2026 came in at -$149.9 million, up 9.46% year-over-year; the trailing twelve-month figure through Mar 2026 was -$594.5 million (up 8.4% YoY), and the FY2025 annual result was -$610.2 million, down 4.03% from the prior year.
• Free Cash Flow came in at -$149.9 million for Q1 2026 at Biohaven, down from -$130.7 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$45.0 million in Q2 2023 to a low of -$170.8 million in Q4 2024.
• The 5-year median for Free Cash Flow is -$115.4 million (2023), against an average of -$116.8 million.
• Across the five-year window, Free Cash Flow jumped 34.7% in 2023 and tumbled 279.54% in 2024, its largest moves.
• Biohaven's Free Cash Flow stood at -$75.7 million in 2022, then slumped by 52.37% to -$115.4 million in 2023, then sank by 48.06% to -$170.8 million in 2024, then advanced by 23.49% to -$130.7 million in 2025, then slipped by 14.73% to -$149.9 million in 2026.
• The last three Free Cash Flow figures came in at -$149.9 million (Q1 2026), -$130.7 million (Q4 2025), and -$145.7 million (Q3 2025), per Business Quant data.